Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{185632,
        author = {Poonam Shivpujan Vishwakarma and Sonal Sahadev Pawar and Disha kailas Dhamne and Madhavi Ramchandra Patole and Girish Ravindra Kokate and Dr. Rajanikant Tukaram Kakade and Janhavi vitthal vishe},
        title = {Development and Validation of an RP-HPLC Method for the Estimation of Tivozanib in Bulk and Pharmaceutical Dosage Forms},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {5},
        pages = {2386-2394},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=185632},
        abstract = {},
        keywords = {Tivozanib, Fotivda, Tyrosine Kinase Inhibitor, VEGFR, Angiogenesis, TIVO-3, Progression-Free Survival, and Renal Cell Carcinoma.},
        month = {October},
        }